What is the Alkem Laboratories Ltd share price today?

The share price of NSE:ALKEM-EQ on 01 Oct 2026 (as of 15:03:00 IST) is ₹5201.5.

What is the NSE:ALKEM-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:ALKEM-EQ 52 week high low range shows a high of ₹5933.5 and a low of ₹5051.

What is the Alkem Laboratories Ltd market cap?

As on 01 Oct 2026, Alkem Laboratories Ltd market cap is ₹615281000000.

What is the shareholding pattern of Alkem Laboratories Ltd Stock?

The shareholding pattern of Alkem Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 49.7% Foreign Institutional Investors (FII): 10.41% Domestic Institutional Investors (DII): 5.93% Mutual Funds: 16.71% Retail & Others: 17.25% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Alkem Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Alkem Laboratories Ltd is 28.5183, and the Price-to-Book (PB) ratio is 4.5994, as on 01 Oct 2026.

Alkem Laboratories Share Price

5236.00+81.00 (+1.57%)

-4.91% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+1.57%

1 Week

+3.09%

1 Month

+0.31%

3 Month

-8.08%

6 Month

-6.34%

YTD

-4.91%

1 Year

-4.91%

5 Year

+41.51%

10 Year

+219.92%

Max

+279.42%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

5107.00

5030.00

4811.00

High

5252.00

5407.00

5700.00

5882.50

5933.50

About

Alkem Laboratories is a leading Indian pharmaceutical company that provides high-quality medicines to patients. It is one of the largest pharmaceutical companies in the Indian market, with a dominant position Read more

Pharmaceuticals & Drugs

Midcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

ALKEMNSE

LTP

1W Low

1W High

Market cap (₹)

1769.9+8.9 (0.51%)

1722

1855

4,24,202Cr

10064+400 (4.14%)

9621.50

10064

2,64,141Cr

4650+70 (1.53%)

4532

4675

1,74,402Cr

2323+79 (3.52%)

2206.10

2441.90

1,26,811Cr

1240.6+56.2 (4.75%)

1182

1254.20

1,23,685Cr

1368.3+23.3 (1.73%)

1336.70

1368.30

1,11,868Cr

1396.9+38.9 (2.86%)

1357

1396.90

1,11,650Cr

2475+5.7 (0.23%)

2457.90

2528

1,02,196Cr

1694.5+34.6 (2.08%)

1647.20

1697.40

96,951Cr

2015.9+26 (1.31%)

1974

2033.80

91,301Cr

5236+157 (3.09%)

5030

5252

61,576Cr

Alkem Laboratories Share Price

5236.00+81.00 (+1.57%)

-4.91% past 1 Year

Financial overview

Compounded Sales Growth

10 years12%

5 years11%

3 years8%

Last year13%

Compounded Profit Growth

10 years12%

5 years8%

3 years33%

Last year6%

Stock Price CAGR

10 years12%

5 years7%

3 years11%

1 year-6%

Return on Equity

10 years18%

5 years18%

3 years19%

Last year18%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
12%	11%	8%	13%
12%	8%	33%	6%
12%	7%	11%	-6%
18%	18%	19%	18%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

ALKEM

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
5,236	₹61576 Cr	28.54	43.49	213.45	₹2302 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015	Mar 2015	Dec 2014
₹3740 Cr	₹3603 Cr	₹3737 Cr	₹4001 Cr	₹3371 Cr	₹3144 Cr	₹3374 Cr	₹3415 Cr	₹3032 Cr	₹2936 Cr	₹3324 Cr	₹3440 Cr	₹2968 Cr	₹2903 Cr	₹3041 Cr	₹3079 Cr	₹2576 Cr	₹2484 Cr	₹2619 Cr	₹2800 Cr	₹2731 Cr	₹2192 Cr	₹2318 Cr	₹2363 Cr	₹1992 Cr	₹2049 Cr	₹2182 Cr	₹2264 Cr	₹1850 Cr	₹1853 Cr	₹1926 Cr	₹1919 Cr	₹1659 Cr	₹1492 Cr	₹1741 Cr	₹1859 Cr	₹1313 Cr	₹1251 Cr	₹1482 Cr	₹1638 Cr	₹1481 Cr	₹1149 Cr	₹1288 Cr	₹1382 Cr	₹1208 Cr	₹912 Cr	₹988 Cr
₹153 Cr	₹200 Cr	₹143 Cr	₹104 Cr	₹136 Cr	₹146 Cr	₹93 Cr	₹134 Cr	₹120 Cr	₹88 Cr	₹94 Cr	₹63 Cr	₹66 Cr	₹69 Cr	₹45 Cr	₹51 Cr	₹51 Cr	₹21 Cr	₹54 Cr	₹42 Cr	₹47 Cr	₹46 Cr	₹96 Cr	₹36 Cr	₹55 Cr	₹27 Cr	₹28 Cr	₹31 Cr	₹17 Cr	₹29 Cr	₹8 Cr	₹25 Cr	₹27 Cr	₹29 Cr	₹24 Cr	₹30 Cr	₹29 Cr	₹25 Cr	₹25 Cr	₹34 Cr	₹28 Cr	₹104 Cr	₹18 Cr	₹70 Cr	₹48 Cr	₹51 Cr	₹39 Cr
₹3893 Cr	₹3803 Cr	₹3880 Cr	₹4105 Cr	₹3508 Cr	₹3290 Cr	₹3467 Cr	₹3549 Cr	₹3152 Cr	₹3024 Cr	₹3418 Cr	₹3503 Cr	₹3034 Cr	₹2971 Cr	₹3086 Cr	₹3130 Cr	₹2628 Cr	₹2504 Cr	₹2673 Cr	₹2842 Cr	₹2778 Cr	₹2238 Cr	₹2414 Cr	₹2398 Cr	₹2047 Cr	₹2076 Cr	₹2210 Cr	₹2295 Cr	₹1867 Cr	₹1882 Cr	₹1934 Cr	₹1943 Cr	₹1686 Cr	₹1521 Cr	₹1765 Cr	₹1889 Cr	₹1342 Cr	₹1276 Cr	₹1507 Cr	₹1672 Cr	₹1509 Cr	₹1252 Cr	₹1306 Cr	₹1452 Cr	₹1255 Cr	₹962 Cr	₹1027 Cr
₹3074 Cr	₹3192 Cr	₹3004 Cr	₹3174 Cr	₹2720 Cr	₹2865 Cr	₹2700 Cr	₹2741 Cr	₹2504 Cr	₹2617 Cr	₹2686 Cr	₹2767 Cr	₹2651 Cr	₹2628 Cr	₹2520 Cr	₹2703 Cr	₹2449 Cr	₹2230 Cr	₹2198 Cr	₹2248 Cr	₹2209 Cr	₹1970 Cr	₹1858 Cr	₹1833 Cr	₹1537 Cr	₹1827 Cr	₹1788 Cr	₹1868 Cr	₹1641 Cr	₹1676 Cr	₹1660 Cr	₹1601 Cr	₹1498 Cr	₹1429 Cr	₹1418 Cr	₹1439 Cr	₹1249 Cr	₹1129 Cr	₹1240 Cr	₹1353 Cr	₹1233 Cr	₹1017 Cr	₹1075 Cr	₹1152 Cr	₹1022 Cr	₹795 Cr	₹838 Cr
₹919 Cr	₹717 Cr	₹971 Cr	₹1024 Cr	₹876 Cr	₹537 Cr	₹852 Cr	₹887 Cr	₹729 Cr	₹490 Cr	₹801 Cr	₹810 Cr	₹455 Cr	₹422 Cr	₹644 Cr	₹505 Cr	₹255 Cr	₹358 Cr	₹552 Cr	₹666 Cr	₹640 Cr	₹337 Cr	₹626 Cr	₹636 Cr	₹577 Cr	₹331 Cr	₹481 Cr	₹484 Cr	₹282 Cr	₹263 Cr	₹321 Cr	₹388 Cr	₹230 Cr	₹132 Cr	₹384 Cr	₹484 Cr	₹124 Cr	₹174 Cr	₹294 Cr	₹344 Cr	₹299 Cr	₹259 Cr	₹254 Cr	₹326 Cr	₹254 Cr	₹185 Cr	₹210 Cr
₹47 Cr	₹54 Cr	₹42 Cr	₹35 Cr	₹30 Cr	₹28 Cr	₹36 Cr	₹28 Cr	₹29 Cr	₹27 Cr	₹25 Cr	₹30 Cr	₹30 Cr	₹29 Cr	₹27 Cr	₹25 Cr	₹27 Cr	₹17 Cr	₹11 Cr	₹12 Cr	₹13 Cr	₹11 Cr	₹13 Cr	₹18 Cr	₹17 Cr	₹14 Cr	₹17 Cr	₹18 Cr	₹16 Cr	₹7 Cr	₹15 Cr	₹16 Cr	₹16 Cr	₹10 Cr	₹14 Cr	₹18 Cr	₹13 Cr	₹11 Cr	₹12 Cr	₹12 Cr	₹10 Cr	₹10 Cr	₹18 Cr	₹20 Cr	₹22 Cr	₹17 Cr	₹21 Cr
₹772 Cr	₹423 Cr	₹781 Cr	₹896 Cr	₹771 Cr	₹396 Cr	₹731 Cr	₹780 Cr	₹619 Cr	₹367 Cr	₹655 Cr	₹648 Cr	₹353 Cr	₹212 Cr	₹539 Cr	₹402 Cr	₹152 Cr	₹243 Cr	₹464 Cr	₹582 Cr	₹556 Cr	₹258 Cr	₹543 Cr	₹548 Cr	₹493 Cr	₹235 Cr	₹405 Cr	₹410 Cr	₹210 Cr	₹199 Cr	₹258 Cr	₹326 Cr	₹172 Cr	₹81 Cr	₹332 Cr	₹432 Cr	₹81 Cr	₹136 Cr	₹255 Cr	₹307 Cr	₹266 Cr	₹225 Cr	₹213 Cr	₹280 Cr	₹211 Cr	₹150 Cr	₹168 Cr
₹521 Cr	₹252 Cr	₹654 Cr	₹780 Cr	₹668 Cr	₹323 Cr	₹641 Cr	₹702 Cr	₹550 Cr	₹304 Cr	₹604 Cr	₹615 Cr	₹288 Cr	₹68 Cr	₹460 Cr	₹348 Cr	₹131 Cr	₹108 Cr	₹533 Cr	₹559 Cr	₹480 Cr	₹249 Cr	₹464 Cr	₹482 Cr	₹423 Cr	₹192 Cr	₹390 Cr	₹381 Cr	₹187 Cr	₹171 Cr	₹205 Cr	₹260 Cr	₹137 Cr	₹66 Cr	₹181 Cr	₹327 Cr	₹64 Cr	₹137 Cr	₹236 Cr	₹288 Cr	₹243 Cr	₹87 Cr	₹190 Cr	₹272 Cr	₹204 Cr	₹132 Cr	₹161 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹24 Cr	₹12 Cr	₹12 Cr	₹12 Cr	₹12 Cr
₹36 Cr	₹36 Cr	₹20 Cr	₹60 L	₹60 L	₹1 Cr	₹1 Cr	₹2 Cr	₹99 L	₹39 L	₹2 L	₹0	₹0	₹0	₹0	₹0
₹13761 Cr	₹11925 Cr	₹10269 Cr	₹9021 Cr	₹8613 Cr	₹7352 Cr	₹6135 Cr	₹5414 Cr	₹4839 Cr	₹4443 Cr	₹3668 Cr	₹2975 Cr	₹2573 Cr	₹2165 Cr	₹1808 Cr	₹1422 Cr
₹13761 Cr	₹11925 Cr	₹10269 Cr	₹9021 Cr	₹8613 Cr	₹7352 Cr	₹6135 Cr	₹5414 Cr	₹4839 Cr	₹4443 Cr	₹3668 Cr	₹2975 Cr	₹2573 Cr	₹2165 Cr	₹1808 Cr	₹1422 Cr
₹13820 Cr	₹11985 Cr	₹10312 Cr	₹9045 Cr	₹8638 Cr	₹7377 Cr	₹6161 Cr	₹5439 Cr	₹4864 Cr	₹4468 Cr	₹3692 Cr	₹2999 Cr	₹2585 Cr	₹2177 Cr	₹1820 Cr	₹1434 Cr
₹529 Cr	₹449 Cr	₹402 Cr	₹390 Cr	₹209 Cr	₹181 Cr	₹148 Cr	₹133 Cr	₹122 Cr	₹115 Cr	₹95 Cr	₹86 Cr	₹0	₹0	₹19 L	₹2 Cr
₹40 Cr	₹62 Cr	₹40 Cr	₹0	₹3 L	₹18 Cr	₹64 Cr	₹220 Cr	₹122 Cr	₹175 Cr	₹112 Cr	₹33 Cr	₹232 Cr	₹256 Cr	₹309 Cr	₹246 Cr
₹453 Cr	₹248 Cr	₹0	₹0	₹9 Cr	₹9 Cr	₹10 Cr	₹12 Cr	₹9 Cr	₹7 Cr	₹11 Cr	₹0	₹0	₹2 L	₹0	₹0
-₹1804 Cr	-₹1738 Cr	-₹1515 Cr	-₹1303 Cr	-₹1309 Cr	-₹1108 Cr	-₹933 Cr	-₹707 Cr	-₹654 Cr	-₹696 Cr	-₹515 Cr	₹92 Cr	₹42 Cr	₹49 Cr	₹36 Cr	₹25 Cr
₹803 Cr	₹641 Cr	₹526 Cr	₹245 Cr	₹74 Cr	₹79 Cr	₹95 Cr	₹13 Cr	₹14 Cr	₹11 Cr	₹3 Cr	₹9 Cr	₹8 Cr	₹12 Cr	₹19 L	₹67 L
₹431 Cr	₹338 Cr	₹300 Cr	₹369 Cr	₹333 Cr	₹251 Cr	₹223 Cr	₹174 Cr	₹150 Cr	₹102 Cr	₹83 Cr	₹67 Cr	₹42 Cr	₹44 Cr	₹180 Cr	₹162 Cr
-₹78 Cr	-₹448 Cr	-₹649 Cr	-₹688 Cr	-₹893 Cr	-₹751 Cr	-₹541 Cr	-₹289 Cr	-₹359 Cr	-₹401 Cr	-₹306 Cr	₹201 Cr	₹324 Cr	₹362 Cr	₹525 Cr	₹434 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹2244 Cr	₹1937 Cr	₹1748 Cr	₹1165 Cr	₹1173 Cr	₹1069 Cr	₹954 Cr	₹962 Cr	₹961 Cr	₹741 Cr	₹580 Cr	₹466 Cr	₹306 Cr	₹288 Cr	₹276 Cr	₹168 Cr
₹1186 Cr	₹1068 Cr	₹892 Cr	₹839 Cr	₹771 Cr	₹643 Cr	₹555 Cr	₹428 Cr	₹520 Cr	₹339 Cr	₹366 Cr	₹327 Cr	₹201 Cr	₹188 Cr	₹111 Cr	₹87 Cr
₹1085 Cr	₹735 Cr	₹1173 Cr	₹1307 Cr	₹2571 Cr	₹1636 Cr	₹1504 Cr	₹671 Cr	₹761 Cr	₹472 Cr	₹464 Cr	₹1129 Cr	₹845 Cr	₹1210 Cr	₹670 Cr	₹663 Cr
₹267 Cr	₹220 Cr	₹182 Cr	₹396 Cr	₹290 Cr	₹256 Cr	₹232 Cr	₹156 Cr	₹141 Cr	₹137 Cr	₹127 Cr	₹84 Cr	₹50 Cr	₹46 Cr	₹63 Cr	₹64 Cr
₹4783 Cr	₹3961 Cr	₹3995 Cr	₹3707 Cr	₹4805 Cr	₹3604 Cr	₹3245 Cr	₹2218 Cr	₹2383 Cr	₹1690 Cr	₹1538 Cr	₹2006 Cr	₹1403 Cr	₹1732 Cr	₹1121 Cr	₹982 Cr
₹19054 Cr	₹15953 Cr	₹14060 Cr	₹12454 Cr	₹12760 Cr	₹10411 Cr	₹9013 Cr	₹7501 Cr	₹7010 Cr	₹5872 Cr	₹5018 Cr	₹5291 Cr	₹4311 Cr	₹4271 Cr	₹3466 Cr	₹2852 Cr
₹1113 Cr	₹881 Cr	₹92 Cr	₹285 Cr	₹269 Cr	₹292 Cr	₹271 Cr	₹320 Cr	₹250 Cr	₹261 Cr	₹242 Cr	₹234 Cr	₹147 Cr	₹121 Cr	₹115 Cr	₹75 Cr
₹1624 Cr	₹1063 Cr	₹1214 Cr	₹1307 Cr	₹2580 Cr	₹1701 Cr	₹1616 Cr	₹944 Cr	₹998 Cr	₹659 Cr	₹658 Cr	₹1306 Cr	₹1128 Cr	₹1549 Cr	₹1005 Cr	₹909 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹6070 Cr	₹4720 Cr	₹4544 Cr	₹4050 Cr	₹4186 Cr	₹3723 Cr	₹3607 Cr	₹3026 Cr	₹2604 Cr	₹1977 Cr	₹1539 Cr	₹1745 Cr	₹1170 Cr	₹1072 Cr	₹919 Cr	₹693 Cr
₹2199 Cr	₹1867 Cr	₹1671 Cr	₹1367 Cr	₹1284 Cr	₹930 Cr	₹699 Cr	₹496 Cr	₹320 Cr	₹180 Cr	₹89 Cr	₹371 Cr	₹0	₹0	₹0	₹0
₹3871 Cr	₹2852 Cr	₹2873 Cr	₹2683 Cr	₹2902 Cr	₹2793 Cr	₹2908 Cr	₹2530 Cr	₹2284 Cr	₹1797 Cr	₹1450 Cr	₹1374 Cr	₹1170 Cr	₹1072 Cr	₹919 Cr	₹693 Cr
₹138 Cr	₹477 Cr	₹148 Cr	₹310 Cr	₹339 Cr	₹393 Cr	₹363 Cr	₹493 Cr	₹381 Cr	₹299 Cr	₹172 Cr	₹111 Cr	₹0	₹0	₹0	₹0
₹1132 Cr	₹943 Cr	₹335 Cr	₹305 Cr	₹232 Cr	₹154 Cr	₹92 Cr	₹96 Cr	₹98 Cr	₹259 Cr	₹234 Cr	₹420 Cr	₹338 Cr	₹410 Cr	₹299 Cr	₹6 Cr
₹1132 Cr	₹943 Cr	₹335 Cr	₹305 Cr	₹232 Cr	₹154 Cr	₹92 Cr	₹96 Cr	₹98 Cr	₹259 Cr	₹234 Cr	₹420 Cr	₹338 Cr	₹410 Cr	₹299 Cr	₹6 Cr
₹364 Cr	₹278 Cr	₹204 Cr	₹139 Cr	₹154 Cr	₹94 Cr	₹91 Cr	₹111 Cr	₹134 Cr	₹185 Cr	₹142 Cr	₹542 Cr	₹418 Cr	₹339 Cr	₹259 Cr	₹154 Cr
₹1195 Cr	₹385 Cr	₹79 Cr	₹275 Cr	₹697 Cr	₹49 Cr	₹54 Cr	₹54 Cr	₹100 Cr	₹414 Cr	₹251 Cr	₹506 Cr	₹783 Cr	₹293 Cr	₹677 Cr	₹460 Cr
₹6843 Cr	₹5007 Cr	₹3648 Cr	₹3724 Cr	₹4325 Cr	₹3483 Cr	₹3507 Cr	₹3284 Cr	₹2997 Cr	₹2955 Cr	₹2250 Cr	₹2953 Cr	₹2709 Cr	₹2115 Cr	₹2153 Cr	₹1313 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹737 Cr	₹902 Cr	₹149 Cr	₹317 Cr	₹139 Cr	₹179 Cr	₹170 Cr	₹228 Cr	₹346 Cr	₹294 Cr	₹274 Cr	₹61 Cr	₹250 Cr	₹67 Cr	₹24 Cr	₹48 Cr
₹3333 Cr	₹2922 Cr	₹2661 Cr	₹2608 Cr	₹3006 Cr	₹2312 Cr	₹1819 Cr	₹1500 Cr	₹1442 Cr	₹1206 Cr	₹909 Cr	₹784 Cr	₹620 Cr	₹554 Cr	₹385 Cr	₹251 Cr
₹2979 Cr	₹2466 Cr	₹2253 Cr	₹2132 Cr	₹1885 Cr	₹1607 Cr	₹1649 Cr	₹1248 Cr	₹1081 Cr	₹714 Cr	₹568 Cr	₹527 Cr	₹367 Cr	₹318 Cr	₹247 Cr	₹171 Cr
₹1733 Cr	₹1563 Cr	₹1579 Cr	₹2617 Cr	₹2579 Cr	₹1990 Cr	₹1092 Cr	₹662 Cr	₹577 Cr	₹399 Cr	₹781 Cr	₹791 Cr	₹206 Cr	₹995 Cr	₹514 Cr	₹990 Cr
₹221 Cr	₹156 Cr	₹237 Cr	₹245 Cr	₹240 Cr	₹330 Cr	₹275 Cr	₹162 Cr	₹177 Cr	₹132 Cr	₹95 Cr	₹60 Cr	₹49 Cr	₹106 Cr	₹63 Cr	₹39 Cr
₹3207 Cr	₹2801 Cr	₹3532 Cr	₹688 Cr	₹586 Cr	₹505 Cr	₹482 Cr	₹405 Cr	₹391 Cr	₹171 Cr	₹141 Cr	₹115 Cr	₹110 Cr	₹115 Cr	₹80 Cr	₹40 Cr
₹12211 Cr	₹10811 Cr	₹10412 Cr	₹8606 Cr	₹8434 Cr	₹6923 Cr	₹5488 Cr	₹4204 Cr	₹4013 Cr	₹2915 Cr	₹2769 Cr	₹2338 Cr	₹1602 Cr	₹2156 Cr	₹1312 Cr	₹1539 Cr
₹7428 Cr	₹6851 Cr	₹6417 Cr	₹4899 Cr	₹3628 Cr	₹3319 Cr	₹2243 Cr	₹1987 Cr	₹1630 Cr	₹1226 Cr	₹1231 Cr	₹332 Cr	₹200 Cr	₹424 Cr	₹192 Cr	₹557 Cr
₹19054 Cr	₹15953 Cr	₹14060 Cr	₹12454 Cr	₹12760 Cr	₹10411 Cr	₹9013 Cr	₹7501 Cr	₹7010 Cr	₹5872 Cr	₹5018 Cr	₹5291 Cr	₹4311 Cr	₹4271 Cr	₹3466 Cr	₹2852 Cr
₹1,153	₹999	₹861	₹757	₹722	₹617	₹515	₹455	₹407	₹374	₹309	₹251	₹2,161	₹1,820	₹1,522	₹1,199
₹1,153	₹999	₹861	₹757	₹722	₹617	₹515	₹455	₹407	₹374	₹309	₹251	₹216	₹182	₹152	₹120

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
₹2871 Cr	₹2527 Cr	₹2023 Cr	₹1305 Cr	₹1844 Cr	₹1842 Cr	₹1260 Cr	₹955 Cr	₹926 Cr	₹965 Cr	₹928 Cr	₹451 Cr	₹430 Cr	₹402 Cr	₹433 Cr	₹331 Cr
₹136 Cr	₹104 Cr	₹384 Cr	₹324 Cr	₹209 Cr	₹165 Cr	₹256 Cr	₹216 Cr	₹116 Cr	₹33 Cr	-₹14 Cr	-₹8 Cr	₹7 Cr	-₹31 Cr	-₹33 Cr	-₹18 Cr
-₹415 Cr	-₹214 Cr	-₹52 Cr	₹327 Cr	-₹545 Cr	-₹341 Cr	-₹647 Cr	-₹140 Cr	-₹573 Cr	-₹263 Cr	₹10 Cr	-₹12 Cr	-₹36 Cr	-₹183 Cr	-₹145 Cr	-₹99 Cr
₹2592 Cr	₹2417 Cr	₹2355 Cr	₹1956 Cr	₹1508 Cr	₹1666 Cr	₹868 Cr	₹1031 Cr	₹469 Cr	₹735 Cr	₹924 Cr	₹431 Cr	₹401 Cr	₹188 Cr	₹256 Cr	₹215 Cr
₹1963 Cr	₹1913 Cr	₹1948 Cr	₹1683 Cr	₹1111 Cr	₹1265 Cr	₹585 Cr	₹780 Cr	₹266 Cr	₹471 Cr	₹726 Cr	₹325 Cr	₹290 Cr	₹78 Cr	₹159 Cr	₹148 Cr
-₹1667 Cr	-₹1299 Cr	-₹1009 Cr	₹113 Cr	-₹1435 Cr	-₹999 Cr	-₹741 Cr	-₹316 Cr	-₹357 Cr	-₹286 Cr	₹202 Cr	-₹237 Cr	₹350 Cr	-₹404 Cr	-₹248 Cr	-₹823 Cr
-₹503 Cr	-₹811 Cr	-₹1145 Cr	-₹1761 Cr	₹380 Cr	-₹272 Cr	₹79 Cr	-₹379 Cr	₹85 Cr	-₹138 Cr	-₹927 Cr	-₹52 Cr	-₹600 Cr	₹356 Cr	-₹11 Cr	₹779 Cr
-₹208 Cr	-₹197 Cr	-₹205 Cr	₹35 Cr	₹55 Cr	-₹5 Cr	-₹77 Cr	₹84 Cr	-₹7 Cr	₹47 Cr	₹83 L	₹37 Cr	₹41 Cr	₹30 Cr	-₹100 Cr	₹104 Cr
-₹120 Cr	₹66 Cr	₹274 Cr	₹232 Cr	₹174 Cr	₹176 Cr	₹249 Cr	₹167 Cr	₹167 Cr	₹127 Cr	₹124 Cr	₹101 Cr	₹57 Cr	₹26 Cr	₹124 Cr	₹20 Cr
-₹14 Cr	₹11 Cr	-₹2 Cr	₹7 Cr	₹3 Cr	₹4 Cr	₹4 Cr	-₹2 Cr	₹7 Cr	-₹8 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹79 L	₹2 Cr	-₹3 L
-₹342 Cr	-₹120 Cr	₹66 Cr	₹274 Cr	₹232 Cr	₹174 Cr	₹176 Cr	₹249 Cr	₹167 Cr	₹167 Cr	₹127 Cr	₹140 Cr	₹101 Cr	₹57 Cr	₹26 Cr	₹124 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Alkem Laboratories Share Price

5236.00+81.00 (+1.57%)

-4.91% past 1 Year

Shareholding summary

Promoters

49.7%

FII

10.32%

DII

5.04%

17.79%

Others

17.15%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
49.70%	49.70%	51.20%	51.20%	51.20%	53.04%
10.32%	10.41%	10.15%	9.97%	9.47%	9.11%
5.04%	5.93%	5.82%	5.48%	4.99%	5.13%
17.79%	16.71%	15.57%	16.06%	16.94%	16.67%
17.15%	17.25%	17.26%	17.29%	17.40%	16.05%

Bulk & block deals

Name

Icici Prudential Mutual Fund

Hdfc Mutual Fund

Morgan Stanley Asia Singapore Pte

Goldman Sachs Bank Europe Se

Icici Prudential Mutual Fund

Jayanti Sinha

Bnp Paribas Arbitrage - Odi

Dsp Mutual Fund

Societe Generale

Nippon India Mutual Fund

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
02 Jun 2026	Purchase	469.83 Cr	₹5,200	9.04 L	Block	0.755679	NSE
02 Jun 2026	Purchase	265 Cr	₹5,200	5.10 L	Block	0.426224	NSE
02 Jun 2026	Purchase	25.01 Cr	₹5,200	48.09 K	Block	0.040221	NSE
02 Jun 2026	Purchase	25.01 Cr	₹5,200	48.09 K	Block	0.040221	NSE
02 Jun 2026	Purchase	469.83 Cr	₹5,200	9.04 L	Bulk	0.755679	NSE
02 Jun 2026	Sell	643.87 Cr	₹5,200	12.38 L	Bulk	1.035604	NSE
02 Jun 2026	Purchase	25.01 Cr	₹5,200	48.09 K	Block	0.040221	NSE
02 Jun 2026	Purchase	45 Cr	₹5,200	86.54 K	Block	0.072377	NSE
02 Jun 2026	Purchase	25.01 Cr	₹5,200	48.09 K	Block	0.040221	NSE
02 Jun 2026	Purchase	25.01 Cr	₹5,200	48.09 K	Block	0.040221	NSE

Insider trading & SAST

Client name

Hdfc Mutual Fund

Prudential Mutual Fund

Icici Prudential Mutual Fund

Mr. Deepak Kumar Singh

Mritunjay Kumar Singh

Dhananjay And Madhurima Singh Trust

Mr. Deepak Kumar Singh

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
10 Sep 2026	Other	Acquisition	0.02	5.01	0	—	25.02 K	24 Aug 2026	Market	59,98,428	SAST	29(1)	—
11 Feb 2026	Other	Disposal	2.1	3.12	0	—	25.09 L	05 Jun 2025 - 14 Jan 2026	Market	37,30,488	SAST	29(2)	—
17 Jun 2025	Other	Acquisition	0.73	5.22	0	—	8.70 L	04 Jun 2025	Market	62,39,470	SAST	29(1)	—
29 Mar 2022	Designated Person	Disposal	0.020912	2.41	9.02 Cr	₹3,609.42	25 K	28 Mar 2022	Market Sale	28,85,013	Insider Trading	—	Equity Shares
08 Mar 2022	Promoter & Director	Acquisition	0.002808	6.38	1.07 Cr	₹3,184.95	3.36 K	04 Mar 2022	Market Purchase	76,28,357	Insider Trading	—	Equity Shares
08 Mar 2022	Promoter & Director	Acquisition	0.001374	6.38	51.89 L	₹3,158.04	1.64 K	07 Mar 2022	Market Purchase	76,30,000	Insider Trading	—	Equity Shares
25 Feb 2022	Promoter	Acquisition	0.000878	0	34.39 L	₹3,275	1.05 K	23 Feb 2022	Market Purchase	3,055	Insider Trading	—	Equity Shares
23 Feb 2022	Promoter	Acquisition	0.001673	0	65.92 L	₹3,295.87	2 K	21 Feb 2022 - 22 Feb 2022	Market Purchase	2,005	Insider Trading	—	Equity Shares
30 Dec 2021	Designated Person	Disposal	0.001673	2.43	69.82 L	₹3,491.17	2 K	29 Dec 2021	Market Sale	29,10,013	Insider Trading	—	Equity Shares
27 Dec 2021	Designated Person	Disposal	0.001673	2.43	68.75 L	₹3,437.31	2 K	23 Dec 2021	Market Sale	29,12,013	Insider Trading	—	Equity Shares

Alkem Laboratories Share Price

5236.00+81.00 (+1.57%)

-4.91% past 1 Year

Corporate Actions

Date

Type

Details

2026-08-07

Dividend

10.0

2026-02-20

Dividend

43.0

2025-08-08

Dividend

8.0

2025-02-14

Dividend

37.0

2024-08-09

Dividend

5.0

2024-02-16

Dividend

35.0

2023-08-10

Dividend

10.0

2023-02-17

Dividend

25.0

2023-02-17

Dividend

40.0

2022-08-08

Dividend

4.0

2022-02-10

Dividend

30.0

2021-08-09

Dividend

5.0

2021-02-11

Dividend

25.0

2020-08-10

Dividend

3.0

2020-02-13

Dividend

22.0

2019-08-19

Dividend

8.0

2019-02-15

Dividend

8.0

2018-08-23

Dividend

7.0

2018-02-16

Dividend

6.0

2017-08-31

Dividend

9.0

2016-11-23

Dividend

6.0

2016-03-18

Dividend

9.7

Company details

Registered office

Alkem House Senapati Bapat Marg Lower Parel (West) Mumbai Maharashtra PIN: 400013 Tel No: 022 3982 9999 Fax No: 022 2495 2955 Email: [email protected] / [email protected] Internet: www.alkemlabs.com

Registrars

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/

Management

Basudeo N Singh, Chairman

Sandeep Singh, Managing Director

Mritunjay Kumar Singh, Executive Director

Madhurima Singh, Executive Director

Sarvesh Singh, Executive Director

Srinivas Singh, Executive Director

Narendra Kumar Aneja, Non Executive Independent Director

Sujjain Talwar, Non Executive Independent Director

Rajeev Kher, Non Executive Independent Director

Ranjal Laxmana Shenoy, Non Executive Independent Director

Neela Bhattacherjee, Non Executive Independent Director

Diwakar Gupta, Non Executive Independent Director

Manish Narang, President – Legal, Company Secretary & Compliance Officer

Details

BSE 539523

NSE ALKEM

ISIN INE540L01014

Alkem Laboratories Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Alkem Laboratories Share Price

Alkem Laboratories Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Alkem Laboratories Share Price

Alkem Laboratories Share Price

Oscillators

Moving averages

Alkem Laboratories Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Alkem Laboratories Share Price

Corporate Actions

Company details

Alkem Laboratories Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Alkem Laboratories Share Price

News

Alkem Laboratories Appoints Dr Amrut Naik As New Chief Executive Officer

Alkem Laboratories API Facility Clears US FDA Inspection Without Issues

Alkem Audit Committee Approves Grant Thornton Forensic Audit Into Alleged Fund Misuse

Alkem Reports Rs 26.69 Crores NSE Block Trade At Rs 5274

Alkem Laboratories Reports BSE Block Trade Worth Rs 26.65 Crores

Alkem Laboratories Co Chief Financial Officer Resigns From Senior Management

Alkem Laboratories launches Neuceno for adult partial-onset seizure treatment in India

Alkem Laboratories NSE block trade of Rs 49.56 crores reported

Alkem launches patented Renocia Exo ginsenoside exosome hair growth serum

Alkem Laboratories sees Rs 21.61 crores NSE block trade in equity shares

Investec upgrades Alkem Laboratories to Buy on strong earnings outlook

Macquarie maintains UNDERPERFORM on Alkem Labs with Rs 4,900 target price

JPMORGAN maintains neutral rating on Alkem Labs with Rs 6,100 target

Alkem Labs approves investment of up to Rs 75 crores

Alkem Labs reports higher Q1 revenue versus last year

Alkem Labs reports higher EBITDA in Q1, margin declines year on year

Alkem Lab reports lower Q1 net profit year on year

Alkem Laboratories NSE block trade worth Rs 36.84 crores executed

Alkem Labs sees Rs 102.41 crore BSE block trade at notable premium pricing

Alkem Labs sees Rs 56.74 crore NSE block trade at Rs 5,636

Alkem Laboratories Ltd Share Price Today

Alkem Laboratories Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator